医学
克罗恩病
疾病
荟萃分析
克罗恩病
维持疗法
梅德林
内科学
胃肠病学
化疗
政治学
法学
作者
Mohammad Shehab,Fatema Al‐Rashed,Abdulrahman Alrashidi,Amro Hassan,Christopher Ma,Neeraj Narula,Vipul Jairath,Miguel Regueiro,Talat Bessissow
摘要
Novel IL-23 inhibitors (such as mirikizumab, risankizumab and guselkumab) and anti-TNFs (such as infliximab and adalimumab) ranked high in the induction of clinical and endoscopic remission. This highlights the potential of novel advanced therapies for CD.
科研通智能强力驱动
Strongly Powered by AbleSci AI